Objective:
Our client wanted, eQuantX to perform a market access and expansion study in South east countries (India, China, Taiwan, Vietnam & Singapore) in order to understand the current market opportune for IVD product and proposing a market entry strategy for them;
- To perform a detailed market assessment study focused on the specific IVD segments i.e. Immunoassay; Hematology and Clinical-chemistry
- Segmentation of hospital into primary, secondary and tertiary care and estimation of their annual budget on in-vitro diagnostic segments
- Identifying and quantifying the major diagnostics labs aligned to the services segment and their value chain
- Build a adoption curve of diagnostic automation in specific countries and mapping the decision making process with respect to their organization type
- Understanding the current and future trend of the market with respect to evolution of advance technology and automations major trends in pathological laboratory space
- Market size, share and value chain across Immunochemistry, Hematology and Clinical-chemistry labs
Approach
In alignment with the above objectives, we proposed a hybrid methodology integrating both secondary and primary research methods-
Secondary Research: Utilizing published articles, journals, white papers, annual reports and filings, company websites, as well as relevant data from government sources such as ministries of health and regulatory authority sites, alongside other publicly available information.
Primary Research: Engaging with Key Opinion Leaders (KOLs), specialists, technicians, pathologists, and ex-employees of competitor companies to gather insights. Additionally, reaching out to key distributors, customers including hospitals and clinics in both private and public settings. Furthermore, engaging with regulatory bodies and payers in the specified regions of India, China, Taiwan, Vietnam, and Singapore have provided valuable perspectives.
This hybrid approach ensures comprehensive coverage and depth in gathering data and insights across the specific IVD segments, segmentation of hospitals, and identification of diagnostics labs, understanding adoption curves, and assessing market trends and dynamics across different geographies.
Outcomes
The study has successfully identified and quantified major diagnostics labs across the given markets, aligned with the services segment, explaining their value chains and market positioning.
Moreover, the adoption curve of diagnostic automation across specific countries has been mapped, and identifying the decision-making processes within different organization types.
Furthermore, insights into current and future market trends regarding the evolution of advanced technology and automation in the pathological laboratory space have been provided.
Market size, share, and value chain across Immunochemistry, Hematology, and Clinical-chemistry labs has provided a holistic understanding of the market landscape with the detailed competitor profiling of the key players in each of the markets.
